{"id":"placebo-depot","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL1200775","moleculeType":"Protein","molecularWeight":"1269.47"},"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"Placebo depot is designed to mimic the administration process of an active drug without containing any active ingredients, thereby helping to isolate the effects of the active treatment in clinical studies.","oneSentence":"Placebo depot does not have an active pharmacological mechanism; it is used as a control in clinical trials.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:26:48.025Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT04484818","phase":"PHASE3","title":"Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2021-03-01","conditions":"Prostate Carcinoma","enrollment":27},{"nctId":"NCT03418038","phase":"PHASE2","title":"Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-03-23","conditions":"Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent Diffuse Large B-Cell Lymphoma","enrollment":80},{"nctId":"NCT02743455","phase":"PHASE1","title":"A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-07-05","conditions":"Yellow Fever, Yellow Fever Immunisation","enrollment":92},{"nctId":"NCT03583255","phase":"PHASE2","title":"Physical Activity With or Without Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Locally Advanced, Metastatic, or Recurrent Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-06-29","conditions":"Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid System Neoplasm, Locally Advanced Malignant Solid Neoplasm","enrollment":99},{"nctId":"NCT05281328","phase":"PHASE2, PHASE3","title":"A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Camurus AB","startDate":"2022-06-28","conditions":"Polycystic Liver Disease","enrollment":71},{"nctId":"NCT03367156","phase":"PHASE2","title":"Dexamethasone in Controlling Dyspnea in Patients With Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-12-04","conditions":"Dyspnea, Malignant Neoplasm","enrollment":135},{"nctId":"NCT03367572","phase":"PHASE3","title":"Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer","status":"COMPLETED","sponsor":"University of Rochester NCORP Research Base","startDate":"2018-04-19","conditions":"Breast Carcinoma","enrollment":1363},{"nctId":"NCT04478266","phase":"PHASE3","title":"Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer","status":"TERMINATED","sponsor":"Sanofi","startDate":"2020-10-14","conditions":"Breast Cancer","enrollment":1068},{"nctId":"NCT03649724","phase":"PHASE2","title":"The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2020-11-27","conditions":"Alzheimer Disease, Mild Cognitive Impairment","enrollment":180},{"nctId":"NCT02319837","phase":"PHASE3","title":"Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2014-12-17","conditions":"Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate","enrollment":1068},{"nctId":"NCT00687739","phase":"PHASE3","title":"Prevention of Obesity in Women Via Estradiol Regulation","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2008-05","conditions":"Obesity","enrollment":79},{"nctId":"NCT03792555","phase":"PHASE2","title":"A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve)","status":"COMPLETED","sponsor":"Crinetics Pharmaceuticals Inc.","startDate":"2019-03-11","conditions":"Acromegaly","enrollment":13},{"nctId":"NCT06778213","phase":"PHASE4","title":"Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure chamber-a Randomized Placebo-controlled Double-blind Study","status":"RECRUITING","sponsor":"Wroclaw Medical University","startDate":"2024-11-02","conditions":"Allergic Rhinoconjunctivitis","enrollment":67},{"nctId":"NCT00696111","phase":"NA","title":"Metabolic Study of Women With Polycystic Ovary Syndrome and Sleep Apnea","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2007-12","conditions":"Polycystic Ovary Syndrome, Obstructive Sleep Apnea","enrollment":18},{"nctId":"NCT02196155","phase":"NA","title":"Botulinum Toxin A Versus Steroids for the Treatment of Chronic Plantar Fasciitis","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2016-07","conditions":"Plantar Fasciitis","enrollment":54},{"nctId":"NCT03557931","phase":"PHASE2","title":"A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication","status":"COMPLETED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2018-07-13","conditions":"Schizophrenia","enrollment":233},{"nctId":"NCT03844633","phase":"PHASE4","title":"Postpartum Family Planning","status":"TERMINATED","sponsor":"Ohio State University","startDate":"2019-03-21","conditions":"Delay in Time to Lactogenesis Stage II","enrollment":49},{"nctId":"NCT04076462","phase":"PHASE3","title":"A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly","status":"COMPLETED","sponsor":"Camurus AB","startDate":"2019-08-19","conditions":"Acromegaly","enrollment":72},{"nctId":"NCT04121221","phase":"PHASE3","title":"A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Injection of GA Depot in Subjects With RMS","status":"COMPLETED","sponsor":"Mapi Pharma Ltd.","startDate":"2019-09-19","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":1016},{"nctId":"NCT02203331","phase":"PHASE2","title":"Bay98-7196, Dose Finding / POC Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2014-10-16","conditions":"Endometriosis","enrollment":319},{"nctId":"NCT05525780","phase":"PHASE1","title":"Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Donepezil From Single Dose of GB-5001 IM Depot and Aricept® Oral Tablets in Healthy Male Volunteers","status":"COMPLETED","sponsor":"G2GBio, Inc.","startDate":"2022-08-26","conditions":"Alzheimer Disease","enrollment":48},{"nctId":"NCT00203996","phase":"PHASE4","title":"Polycystic Ovary Syndrome (PCOS) and Sleep Apnea","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2003-09","conditions":"Polycystic Ovary Syndrome, Obstructive Sleep Apnea","enrollment":37},{"nctId":"NCT00001259","phase":"PHASE1","title":"A Treatment Study for Premenstrual Syndrome (PMS)","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"1992-08-11","conditions":"Premenstrual Syndrome, Menstruation Disturbances","enrollment":60},{"nctId":"NCT01613495","phase":"NA","title":"Ghrelin Suppression by Octreotide in Prader-Willi","status":"UNKNOWN","sponsor":"Oregon Health and Science University","startDate":"2005-08","conditions":"Prader Willis Syndrome","enrollment":2},{"nctId":"NCT00774930","phase":"PHASE3","title":"An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome","status":"COMPLETED","sponsor":"Ipsen","startDate":"2009-05","conditions":"Carcinoid Syndrome","enrollment":115},{"nctId":"NCT00842348","phase":"PHASE3","title":"Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine Tumour","status":"COMPLETED","sponsor":"Ipsen","startDate":"2009-02","conditions":"Non Functioning Entero-pancreatic Endocrine Tumour","enrollment":89},{"nctId":"NCT02543944","phase":"PHASE2, PHASE3","title":"Improving Treatment Outcomes for Prescription Opioid Dependence","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2016-02","conditions":"Drug Dependence","enrollment":117},{"nctId":"NCT04225221","phase":"PHASE2","title":"Neurobiology of Bulimia Nervosa","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2020-02-24","conditions":"Bulimia Nervosa","enrollment":10},{"nctId":"NCT02683941","phase":"PHASE3","title":"Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg vs. Placebo in Subjects With Lung Neuroendocrine Tumours","status":"TERMINATED","sponsor":"Ipsen","startDate":"2017-03-06","conditions":"Neuroendocrine Tumors in Lung","enrollment":77},{"nctId":"NCT02975479","phase":"PHASE2, PHASE3","title":"Intralymphatic Immunotherapy in Increasing Doses, Substudy","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2016-05","conditions":"Rhinitis, Allergic, Seasonal","enrollment":40},{"nctId":"NCT05009290","phase":"PHASE3","title":"A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy","status":"RECRUITING","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2021-11-01","conditions":"Patients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy","enrollment":1256},{"nctId":"NCT02122198","phase":"NA","title":"Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2014-09-08","conditions":"Cognitive Impairment, Executive Dysfunction, Endothelial Dysfunction","enrollment":17},{"nctId":"NCT02604446","phase":"PHASE3","title":"Depot-opioids for Pre- and Postoperative Pain Relief After Primary Knee Arthroplasty.Tapentadol vs Oxycodone vs Placebo","status":"COMPLETED","sponsor":"St. Olavs Hospital","startDate":"2015-09","conditions":"Joint Diseases","enrollment":134},{"nctId":"NCT02946073","phase":"PHASE3","title":"Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain","status":"COMPLETED","sponsor":"Braeburn Pharmaceuticals","startDate":"2016-09","conditions":"Chronic Lower Back Pain, Chronic Pain","enrollment":1053},{"nctId":"NCT02914509","phase":"PHASE3","title":"Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT","status":"COMPLETED","sponsor":"Ocular Therapeutix, Inc.","startDate":"2016-11-07","conditions":"Open Angle Glaucoma, Ocular Hypertension","enrollment":565},{"nctId":"NCT04541485","phase":"PHASE1","title":"To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)","status":"TERMINATED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2020-12-04","conditions":"COVID-19 Patients","enrollment":2},{"nctId":"NCT05017428","phase":"NA","title":"Absorption and Digestion Kinetics of Human Metabolites","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2021-04-08","conditions":"Postprandial Inflammation","enrollment":5},{"nctId":"NCT03112226","phase":"NA","title":"Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2018-02-07","conditions":"Cognitive Impairment, Estrogen Deficiency, Menopause","enrollment":19},{"nctId":"NCT00124514","phase":"PHASE2","title":"Triptorelin for Ovary Protection in Childhood Onset Lupus","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2003-06","conditions":"Systemic Lupus Erythematosus","enrollment":31},{"nctId":"NCT03172871","phase":"PHASE3","title":"Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia","status":"COMPLETED","sponsor":"Otsuka Beijing Research Institute","startDate":"2017-05-15","conditions":"Schizophrenia","enrollment":436},{"nctId":"NCT04524052","phase":"PHASE1","title":"To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19","status":"UNKNOWN","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2020-08","conditions":"Healthy","enrollment":32},{"nctId":"NCT04405960","phase":"PHASE3","title":"Role of Alphacalcidol Supplement to Reduce Pain and COMP in Geriatric Knee Osteoarthritis Patients","status":"COMPLETED","sponsor":"Syarif Hidayatullah State Islamic University Jakarta","startDate":"2017-07-01","conditions":"Osteoarthritis, Knee, Aged","enrollment":146},{"nctId":"NCT02492750","phase":"PHASE1","title":"Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2016-04","conditions":"Indolent Plasma Cell Myeloma, Plasma Cell Myeloma, Smoldering Plasma Cell Myeloma","enrollment":14},{"nctId":"NCT01246401","phase":"PHASE1, PHASE2","title":"Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations","status":"COMPLETED","sponsor":"Yale University","startDate":"2011-03","conditions":"HIV, AIDS, Opioid Dependence","enrollment":151},{"nctId":"NCT01712230","phase":"NA","title":"Females, Aging, Metabolism, and Exercise","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2012-10","conditions":"Obesity","enrollment":47},{"nctId":"NCT02651584","phase":"PHASE3","title":"Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence","status":"COMPLETED","sponsor":"Braeburn Pharmaceuticals","startDate":"2015-12","conditions":"Opioid Use Disorders","enrollment":428},{"nctId":"NCT01489020","phase":"PHASE1","title":"Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT)","status":"COMPLETED","sponsor":"Roxall Medicina España S.A","startDate":"2011-01","conditions":"Allergic Rhinoconjunctivitis","enrollment":48},{"nctId":"NCT01567306","phase":"PHASE2","title":"Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense","status":"COMPLETED","sponsor":"Roxall Medicina España S.A","startDate":"2011-10","conditions":"Allergic Rhinoconjunctivitis","enrollment":151},{"nctId":"NCT00218426","phase":"PHASE2, PHASE3","title":"Addiction Treatment in Russia: Oral vs. Naltrexone Implant","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2006-07","conditions":"Heroin Dependence, Opioid-Related Disorders","enrollment":306},{"nctId":"NCT03715634","phase":"PHASE1","title":"Study of a Novel Subcutaneous Depot Formulation of Buprenorphine","status":"COMPLETED","sponsor":"Indivior Inc.","startDate":"2017-09-20","conditions":"Opioid-use Disorder","enrollment":12},{"nctId":"NCT03779438","phase":"NA","title":"17-Alpha-Hydroxyprogesterone Caproate in Pregnant Women With Placenta Previa","status":"UNKNOWN","sponsor":"Aswan University Hospital","startDate":"2019-01-01","conditions":"Placenta Previa","enrollment":300},{"nctId":"NCT00853047","phase":"PHASE2","title":"Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy","status":"COMPLETED","sponsor":"Lexicon Pharmaceuticals","startDate":"2009-03","conditions":"Carcinoid Syndrome","enrollment":23},{"nctId":"NCT00437658","phase":"PHASE2","title":"Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis","status":"COMPLETED","sponsor":"AbbVie","startDate":"2006-12-11","conditions":"Endometriosis","enrollment":252},{"nctId":"NCT00797225","phase":"PHASE2","title":"Efficacy and Safety Study of Elagolix Versus Placebo or Leuprorelin Acetate in Endometriosis","status":"COMPLETED","sponsor":"AbbVie","startDate":"2008-11-26","conditions":"Endometriosis","enrollment":174},{"nctId":"NCT01567527","phase":"PHASE3","title":"Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2012-08","conditions":"Bipolar I Disorder","enrollment":731},{"nctId":"NCT02423707","phase":"PHASE2, PHASE3","title":"Safety and Efficacy Study of Intralymphatic Allergen-specific Immunotherapy","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2010-08","conditions":"Allergic Rhinitis","enrollment":110},{"nctId":"NCT01748942","phase":"NA","title":"Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer","status":"COMPLETED","sponsor":"OHSU Knight Cancer Institute","startDate":"2012-12","conditions":"Dysphagia, Pain, Stage I Oropharyngeal Squamous Cell Carcinoma","enrollment":76},{"nctId":"NCT02044094","phase":"PHASE2","title":"Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder","status":"COMPLETED","sponsor":"Indivior Inc.","startDate":"2013-11","conditions":"Opioid Use Disorder","enrollment":39},{"nctId":"NCT02357901","phase":"PHASE3","title":"Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine","status":"COMPLETED","sponsor":"Indivior Inc.","startDate":"2015-01-28","conditions":"Opioid Dependence, Opioid Related Disorders","enrollment":665},{"nctId":"NCT03121547","phase":"PHASE1, PHASE2","title":"Opioid Induced Gait Variability","status":"COMPLETED","sponsor":"Frederiksberg University Hospital","startDate":"2015-05-19","conditions":"Opioid Induced Motor Disturbances","enrollment":24},{"nctId":"NCT00781898","phase":"PHASE2, PHASE3","title":"Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2008-06","conditions":"Opiate Addiction","enrollment":308},{"nctId":"NCT01257802","phase":"PHASE3","title":"GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases","status":"TERMINATED","sponsor":"Joseph Mccune","startDate":"2011-05","conditions":"Lupus Erythematosus, Systemic, Systemic Vasculitis, Isolated Angiitis of Central Nervous System","enrollment":14},{"nctId":"NCT01077310","phase":"NA","title":"Alcohol Pharmacotherapy for HIV+ Prisoners","status":"COMPLETED","sponsor":"Yale University","startDate":"2010-08","conditions":"Alcohol Dependence, Problem Drinking, Hazardous Drinking","enrollment":100},{"nctId":"NCT01564017","phase":"PHASE2","title":"Dose-response Study With Subcutaneous Immunotherapy of an Standardized Dermatophagoides Pteronyssinus (DPT) Extract","status":"COMPLETED","sponsor":"Roxall Medicina España S.A","startDate":"2012-05","conditions":"Allergic Rhinoconjunctivitis","enrollment":150},{"nctId":"NCT00182754","phase":"PHASE3","title":"Octreotide in Treating Patients With Cancer-Related Malignant Ascites","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2005-10","conditions":"Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific","enrollment":33},{"nctId":"NCT00380406","phase":"PHASE3","title":"PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2007-01","conditions":"Fertility Preservation, Cancer","enrollment":30},{"nctId":"NCT02550119","phase":"NA","title":"Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy","status":"TERMINATED","sponsor":"University of Southern California","startDate":"2006-04-19","conditions":"Malignant Digestive System Neoplasm, Nausea and Vomiting","enrollment":19},{"nctId":"NCT01473953","phase":"PHASE1","title":"Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2011-10","conditions":"Diabetes, Diabetes Mellitus, Type 2, Healthy","enrollment":31},{"nctId":"NCT02335203","phase":"PHASE2","title":"The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy","status":"UNKNOWN","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2015-02","conditions":"Grade 1 Endometrial Endometrioid Adenocarcinoma, Grade 2 Endometrial Endometrioid Adenocarcinoma, Complex Atypical Endometrial Hyperplasia","enrollment":76},{"nctId":"NCT00033605","phase":"PHASE3","title":"Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2002-04","conditions":"Cervical Cancer, Colorectal Cancer, Diarrhea","enrollment":130},{"nctId":"NCT02652884","phase":"PHASE4","title":"Steroids in the Postoperative Transient Hypoparathyroidism Total Thyroidectomy","status":"UNKNOWN","sponsor":"Hospital Italiano de Buenos Aires","startDate":"2016-01","conditions":"Transient Hypoparathyroidism","enrollment":110},{"nctId":"NCT01202591","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of AZD4547 in Combination With Fulvestrant vs. Fulvestrant Alone in ER+ Breast Cancer Patients","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2010-12","conditions":"FGFR Inhibition, Pharmacokinetics, Biomarkers, ER+ Breast Cancer","enrollment":127},{"nctId":"NCT00310492","phase":"PHASE3","title":"Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2006-04","conditions":"Atopic Dermatitis","enrollment":154},{"nctId":"NCT00075868","phase":"PHASE3","title":"Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2003-12","conditions":"Anal Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ","enrollment":233},{"nctId":"NCT01581359","phase":"PHASE4","title":"The Effect of Pre-treatment With GnRH Analogues Prior in Vitro Fertilization in Patients With Endometriosis","status":"COMPLETED","sponsor":"Instituto de Investigacion Sanitaria La Fe","startDate":"2012-03","conditions":"Endometriosis, Infertility","enrollment":200},{"nctId":"NCT01813955","phase":"EARLY_PHASE1","title":"Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia","status":"TERMINATED","sponsor":"University of Copenhagen","startDate":"2011-06","conditions":"Schizophrenia, Cognitive Deficits","enrollment":5},{"nctId":"NCT01663532","phase":"PHASE3","title":"Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2012-10","conditions":"Schizophrenia","enrollment":340},{"nctId":"NCT00412061","phase":"PHASE3","title":"Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2006-12","conditions":"Carcinoid Tumor, Malignant Carcinoid Syndrome","enrollment":429},{"nctId":"NCT01069094","phase":"PHASE1, PHASE2","title":"A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata","status":"COMPLETED","sponsor":"Repros Therapeutics Inc.","startDate":"2004-07","conditions":"Uterine Leiomyomata","enrollment":29},{"nctId":"NCT01630252","phase":"PHASE2","title":"PGL5001 Proof of Concept Study in Inflammatory Endometriosis","status":"COMPLETED","sponsor":"PregLem SA","startDate":"2012-06","conditions":"Endometriosis","enrollment":24},{"nctId":"NCT00706654","phase":"PHASE3","title":"Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2008-09","conditions":"Schizophrenia","enrollment":937},{"nctId":"NCT00141908","phase":"PHASE2","title":"Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate","status":"COMPLETED","sponsor":"American University of Beirut Medical Center","startDate":"2006-10","conditions":"Preterm Delivery","enrollment":290},{"nctId":"NCT00705783","phase":"PHASE3","title":"Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2008-07","conditions":"Schizophrenia","enrollment":843},{"nctId":"NCT00426153","phase":"PHASE2, PHASE3","title":"Octreotide in Severe Polycystic Liver Disease","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2007-01","conditions":"Polycystic Kidney, Autosomal Dominant, Polycystic Liver Disease, Hepatomegaly","enrollment":42},{"nctId":"NCT00332228","phase":"PHASE2","title":"Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2002-06","conditions":"Opiate Dependence","enrollment":125},{"nctId":"NCT00705770","phase":"PHASE2, PHASE3","title":"A Multi-Dose Study With a Treatment for Open-Angle Glaucoma","status":"WITHDRAWN","sponsor":"Alcon Research","startDate":"2008-05","conditions":"Open-Angle Glaucoma","enrollment":""},{"nctId":"NCT01132404","phase":"PHASE1, PHASE2","title":"Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448","status":"TERMINATED","sponsor":"Millennium Pharmaceuticals, Inc.","startDate":"2010-11","conditions":"Prostate Cancer, Prostatic Neoplasms","enrollment":9},{"nctId":"NCT01254799","phase":"PHASE3","title":"Doxycycline in Treatment of Bleeding With Depot Medroxyprogesterone Acetate (DMPA)","status":"COMPLETED","sponsor":"Omar Mamdouh Shaaban","startDate":"2008-01","conditions":"Uterine Hemorrhage","enrollment":68},{"nctId":"NCT00381602","phase":"PHASE2","title":"A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on Hemodialysis","status":"TERMINATED","sponsor":"QLT Inc.","startDate":"2006-09","conditions":"End Stage Renal Disease","enrollment":3},{"nctId":"NCT00356200","phase":"PHASE2","title":"Fluphenazine Decanoate for Psoriasis","status":"TERMINATED","sponsor":"Tufts Medical Center","startDate":"2006-07","conditions":"Psoriasis","enrollment":10},{"nctId":"NCT00253136","phase":"PHASE3","title":"A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia","status":"COMPLETED","sponsor":"Janssen, LP","startDate":"1999-11","conditions":"Schizophrenia, Psychotic Disorders","enrollment":458},{"nctId":"NCT00275262","phase":"PHASE2","title":"A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation","status":"TERMINATED","sponsor":"Abbott","startDate":"2006-02","conditions":"Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma","enrollment":25},{"nctId":"NCT00433173","phase":"NA","title":"Insulin Sensitivity in Men With the Metabolic Syndrome","status":"SUSPENDED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2006-05","conditions":"Metabolic Syndrome","enrollment":72},{"nctId":"NCT00088478","phase":"PHASE3","title":"Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2004-06","conditions":"Schizophrenia","enrollment":402}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo depot","genericName":"Placebo depot","companyName":"Otsuka Pharmaceutical Development & Commercialization, Inc.","companyId":"otsuka-pharmaceutical-development-commercialization-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}